Octagon Capital Advisors’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.18M Sell
177,667
-290,333
-62% -$3.56M 0.48% 27
2025
Q1
$5.15M Buy
+468,000
New +$5.15M 1% 30